Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/153678
Title: The Qcrb inhibitors TB47 and telacebec do not potentiate the activity of clofazimine in mycobacterium abscessus
Authors: Sorayah, Ria
Moraski, Garret C.
Barkan, Daniel
Pethe, Kevin
Keywords: Medicine, Health and Life Sciences
Issue Date: 2021
Source: Sorayah, R., Moraski, G. C., Barkan, D. & Pethe, K. (2021). The Qcrb inhibitors TB47 and telacebec do not potentiate the activity of clofazimine in mycobacterium abscessus. Antimicrobial Agents and Chemotherapy, 65(12), e0096421-. https://dx.doi.org/10.1128/AAC.00964-21
Project: NRF-NRFI06-2020-0004 
Journal: Antimicrobial Agents and Chemotherapy 
Abstract: The antituberculosis drug telacebec is ineffective against Mycobacterium abscessus. A recent study suggested that TB47, a telacebec analogue, potentiated the efficacy of clofazimine against M. abscessus. Here, we report that TB47 not only is ineffective against M. abscessus in vitro but also does not potentiate the activity of clofazimine.
URI: https://hdl.handle.net/10356/153678
ISSN: 0066-4804
DOI: 10.1128/AAC.00964-21
Schools: Lee Kong Chian School of Medicine (LKCMedicine) 
School of Biological Sciences 
Interdisciplinary Graduate School (IGS) 
Rights: © 2021 American Society for Microbiology. All Rights Reserved. This article may be downloaded for personal use only. Any other use requires prior permission of the copyright holder. The Version of Record is available online at http://doi.org/10.1128/AAC.00964-21.
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:LKCMedicine Journal Articles
SBS Journal Articles

Page view(s)

386
Updated on Mar 11, 2025

Download(s) 50

174
Updated on Mar 11, 2025

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.